Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 2/3 1

Status

Completed 38Terminated 6Unknown 3Active not recruiting 3Recruiting 2

Sponsor Class

NIH 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Carcinoma, Non-Small-Cell Lung 79Nasopharyngeal Carcinoma 51Uterine Cervical Neoplasms 44Lung Neoplasms 38Esophageal Neoplasms 32Head and Neck Neoplasms 28Esophageal Squamous Cell Carcinoma 28Squamous Cell Carcinoma of Head and Neck 22Stomach Neoplasms 20Breast Neoplasms 16Small Cell Lung Carcinoma 15Recurrence 12Neoplasm Metastasis 12Nasopharyngeal Neoplasms 12Carcinoma, Squamous Cell 10Ovarian Neoplasms 9Central Nervous System Neoplasms 9Neuroblastoma 8Lymphoma, Large B-Cell, Diffuse 8Pancreatic Neoplasms 7Lymphoma 7Hypopharyngeal Neoplasms 7Triple Negative Breast Neoplasms 6Oropharyngeal Neoplasms 6Neoplasms 6Biliary Tract Neoplasms 6Urinary Bladder Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Large-Cell, Immunoblastic 5Lymphoma, Follicular 5

Interventions

Fluorouracil 5Radiotherapy 3Paclitaxel 3Leucovorin 3Endoscopy 3Cisplatin 3Oxaliplatin 2Neoadjuvant Therapy 2Endoscopy, Digestive System 2Endoscopic Mucosal Resection 2Carboplatin 2tremelimumab 1rucaparib 1rubitecan 1durvalumab 1Taxes 1Surveys and Questionnaires 1Ramucirumab 1Radiation 1Positron Emission Tomography Computed Tomography 1Nivolumab 1Microarray Analysis 1Magnetic Resonance Imaging 1Irinotecan 1High-Throughput Screening Assays 1Genetic Linkage 1Epirubicin 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Drug Therapy 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma Of Esophagus × Cisplatin × Clear all
NCT00041262 2013-08-12

Combination Chemotherapy in Treating Patients With Esophageal Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
1,300 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00002884 2013-08-07

Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

National Cancer Institute (NCI)

Phase 3 Unknown
326 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT00509561 2012-12-18

Cisplatin, Capecitabine, and Radiation Therapy With or Without Cetuximab in Treating Patients With Esophageal Cancer

Wales Cancer Trials Unit

Phase 2/3 Unknown
259 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡